The objective of this research was to characterize the intermolecular interactions between additives and the crystal faces of carbamazepine dihydrate (CBZ(D)) which led to changes in crystal morphology and inhibition of CBZ(D) nucleation. This was accomplished by comparing results from experiments designed to (1) measure the induction time for nucleation, (2) observe changes in crystal morphology, and (3) monitor the solution-mediated anhydrous to dihydrate carbamazepine transformation, with predicted binding energies between additives and crystal faces of CBZ(D). Additives were chosen based on their potential to interact with the molecular moieties present in the crystal faces of CBZ(D), with emphasis on their ability to form hydrogen bond...
The products of reactions of the pharmaceutical amide carbamazepine (CBZ) with strong acids under aq...
The products of reactions of the pharmaceutical amide carbamazepine (CBZ) with strong acids under aq...
This study is based on the heterogeneous nucleation of active pharmaceutical ingredients (APIs) in t...
Intermolecular interactions between additives and drug molecules that lead to changes in nucleation ...
Intermolecular interactions between additives and drug molecules that lead to changes in nucleation ...
The objective of this research was to study the effect that solubilization and adsorption of the sur...
ABSTRACT: The influence of two structurally different anionic surfactants on the anhydrous-to-dihydr...
The influence of two structurally different anionic surfactants on the anhydrous-to-dihydrate transf...
The objective of this research was to study the effects of polymers on the crystallization of specif...
The objective of this research was to study the effects of polymers on the crystallization of specif...
Combining a pharmaceutical active ingredient (API) with a pharmaceutically acceptable agent, to obta...
Co-crystal is believed to improve the solubility and dissolution rates and thus, enhanced the bioav...
Carbamazepine is an active pharmaceutical ingredient with anticonvulsive properties. Cocrystallizati...
Co-crystal is believed to improve the solubility and dissolution rates and thus, enhanced the bioava...
Controlling pharmaceutical polymorphism in crystallization processes represents a major challenge in...
The products of reactions of the pharmaceutical amide carbamazepine (CBZ) with strong acids under aq...
The products of reactions of the pharmaceutical amide carbamazepine (CBZ) with strong acids under aq...
This study is based on the heterogeneous nucleation of active pharmaceutical ingredients (APIs) in t...
Intermolecular interactions between additives and drug molecules that lead to changes in nucleation ...
Intermolecular interactions between additives and drug molecules that lead to changes in nucleation ...
The objective of this research was to study the effect that solubilization and adsorption of the sur...
ABSTRACT: The influence of two structurally different anionic surfactants on the anhydrous-to-dihydr...
The influence of two structurally different anionic surfactants on the anhydrous-to-dihydrate transf...
The objective of this research was to study the effects of polymers on the crystallization of specif...
The objective of this research was to study the effects of polymers on the crystallization of specif...
Combining a pharmaceutical active ingredient (API) with a pharmaceutically acceptable agent, to obta...
Co-crystal is believed to improve the solubility and dissolution rates and thus, enhanced the bioav...
Carbamazepine is an active pharmaceutical ingredient with anticonvulsive properties. Cocrystallizati...
Co-crystal is believed to improve the solubility and dissolution rates and thus, enhanced the bioava...
Controlling pharmaceutical polymorphism in crystallization processes represents a major challenge in...
The products of reactions of the pharmaceutical amide carbamazepine (CBZ) with strong acids under aq...
The products of reactions of the pharmaceutical amide carbamazepine (CBZ) with strong acids under aq...
This study is based on the heterogeneous nucleation of active pharmaceutical ingredients (APIs) in t...